DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Asthma Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Asthma Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Asthma pipeline products, Asthma epidemiology, Asthma market valuations and forecast, Asthma products sales and competitive landscape in the US.
The research is classified into nine sections - Asthma overview including etiology, pathophysiology, and diagnosis, Asthma treatment options, Asthma pipeline products, Asthma market analysis comprising of Asthma epidemiology, key products marketed for Asthma, market valuations and forecast, products sales and market shares.
- Asthma Pipeline: Find out the products in clinical trials for the treatment of Asthma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Asthma Epidemiology: Find out the number of patients diagnosed (prevalence) with Asthma in the US
- Asthma Products: Identify key products marketed and prescribed for Asthma in the US, including trade name, molecule name, and company
- Asthma Product Sales: Find out the sales revenues of Asthma products, both branded and generics, in the US
- Asthma Market Valuations: Find out the market size for Asthma products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Asthma Products Market Share: Find out the market shares for key Asthma products in the US
Key Topics Covered:
- Disease Overview
- Asthma Treatments
- Asthma Pipeline
- US Asthma Epidemiology
- Marketed Drugs for Asthma in US
- US Asthma Market Size
- US Asthma Products Sales
- US Asthma Market Competitive Landscape
- US Asthma Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/rr4whz/us_asthma_market